|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
1R01CA204586-01
|
$425,315
|
$425,315
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$6,078
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$3,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$6,281
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$10,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$24,244
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$25,125
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$130,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$719,839
|
$359,920
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$719,839
|
$287,936
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$10,856
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$20,388
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
5R01CA178383-03
|
$255,216
|
$84,221
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
1R01CA184456-01A1
|
$341,981
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-03
|
$76,654
|
$25,296
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$171,540
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
$8,075
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
$625
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$14,908
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$63,549
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$600
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Urine DNA Kit for monitoring HCC recurrence
|
1R43CA213610-01
|
$300,000
|
$300,000
|
JAIN, SURBHI
|
JBS SCIENCE, INC.
|
|
|
Urban Health Study
|
ZIA CP005782-10067
|
$29,956
|
$29,956
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$5,954
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$14,980
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$186,297
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$45,195
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$2,499
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$4,004
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$12,591
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S1
|
$115,495
|
$5,775
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S2
|
$200,000
|
$10,000
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Hawaii Cancer Center CCSG
|
4P30CA071789-17
|
$1,913,800
|
$95,690
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
2P30CA023074-36
|
$3,533,423
|
$247,340
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-36S1
|
$125,000
|
$8,750
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-36S2
|
$744,675
|
$52,127
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-03
|
$626,991
|
$15,675
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)
|
5R01CA121275-08
|
$316,102
|
$316,102
|
LEONE, GUSTAVO
|
OHIO STATE UNIVERSITY
|
|
|
Tumor antigen-specific T-cells and hepatocellular carcinoma
|
4R01CA166111-04
|
$332,000
|
$332,000
|
KAPLAN, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-03
|
$315,400
|
$315,400
|
HORUZSKO, ANATOLIJ
|
GEORGIA REGENTS UNIVERSITY
|
|
|
Translational Research in Cancer
|
3P30CA056036-17S1
|
$117,000
|
$12,870
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
4P30CA056036-17
|
$2,807,751
|
$308,853
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Tissue Homeostatic Control by CSF-dependent Macrophage-Stromal Cell Interactions
|
5F30CA186626-03
|
$48,576
|
$24,288
|
JACOX, JEREMY
|
YALE UNIVERSITY
|
|
|
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
|
ZID BC 011540
|
$1,518,237
|
$303,647
|
Hassan, Raffit
|
CCR (NCI)
|
|
Total relevant funding to Liver Cancer for this search: $75,693,176
|
